Walvax Biotechnology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000WN2
CNY
11.71
0.92 (8.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,802.56
4,081.75
5,053.19
3,443.01
2,921.65
1,112.25
869.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,802.56
4,081.75
5,053.19
3,443.01
2,921.65
1,112.25
869.04
Raw Material Cost
756.59
683.77
668.34
438.81
426.96
271.76
227.02
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
341.64
243.85
170.83
125.52
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.75
6.30
7.86
6.47
2.08
32.67
39.98
Selling and Distribution Expenses
1,145.01
1,830.79
2,264.49
1,570.64
1,287.90
602.84
475.32
Other Expenses
49.71
73.17
89.90
24.94
-7.97
-16.85
-6.25
Total Expenditure (Excl Depreciation)
2,407.42
3,252.60
3,839.68
2,606.99
1,881.07
909.57
805.34
Operating Profit (PBDIT) excl Other Income
395.09999999999997
829.0999999999999
1213.5
836
1040.6
202.7
63.7
Other Income
214.67
186.38
165.44
174.95
65.90
55.34
1,162.78
Operating Profit (PBDIT)
703.03
1,173.58
1,554.32
1,151.74
1,230.31
332.14
1,343.24
Interest
8.75
6.30
7.86
6.47
2.08
32.67
39.98
Exceptional Items
-98.34
-235.35
-199.42
-285.84
273.29
9.74
-1.87
Gross Profit (PBDT)
2,045.97
3,397.98
4,384.86
3,004.19
2,494.69
840.49
642.02
Depreciation
411.57
333.34
275.50
149.55
128.40
82.22
127.06
Profit Before Tax
184.37
598.59
1,071.54
709.88
1,373.12
226.99
1,174.33
Tax
10.10
87.65
132.24
107.59
162.12
35.33
120.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
142.16
419.39
728.65
427.75
1,003.19
141.97
1,046.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
142.16
419.39
728.65
427.75
1,003.19
141.97
1,046.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
32.24
91.93
209.57
173.60
208.00
52.16
16.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
174.40
511.33
938.23
601.35
1,211.19
194.14
1,062.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
9,429.54
9,349.28
9,083.97
8,484.23
6,544.76
4,865.16
4,579.94
Earnings per share (EPS)
0.09
0.26
0.45
0.27
0.65
0.09
0.68
Diluted Earnings per share
0.09
0.26
0.45
0.27
0.65
0.09
0.68
Operating Profit Margin (Excl OI)
2.74%
16.02%
22.03%
24.03%
35.46%
17.49%
6.14%
Gross Profit Margin
21.26%
22.83%
26.66%
24.96%
51.39%
27.8%
149.75%
PAT Margin
5.07%
10.27%
14.42%
12.42%
34.34%
12.76%
120.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -31.34% vs -19.23% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -65.89% vs -45.50% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -50.53% vs -28.92% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 38.10% vs -20.25% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Walvax Biotechnology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,802.56
0
2,802.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,802.56
0
2,802.56
Raw Material Cost
756.59
0
756.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.75
0
8.75
Selling and Distribution Expenses
1,145.01
0
1,145.01
Other Expenses
49.71
0.00
49.71
Total Expenditure (Excl Depreciation)
2,407.42
0
2,407.42
Operating Profit (PBDIT) excl Other Income
395.14
0.00
395.14
Other Income
214.67
0
214.67
Operating Profit (PBDIT)
703.03
0
703.03
Interest
8.75
0
8.75
Exceptional Items
-98.34
0
-98.34
Gross Profit (PBDT)
2,045.97
0
2,045.97
Depreciation
411.57
0
411.57
Profit Before Tax
184.37
0
184.37
Tax
10.10
0
10.10
Provisions and contingencies
0
0
0.00
Profit After Tax
142.16
0
142.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
142.16
0
142.16
Share in Profit of Associates
0
0
0.00
Minority Interest
32.24
0
32.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
174.40
0
174.40
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
9,429.54
0
9,429.54
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
2.74%
0%
0.00
2.74%
Gross Profit Margin
21.26%
0%
0.00
21.26%
PAT Margin
5.07%
0%
0.00
5.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 280.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -31.34% vs -19.23% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 17.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -65.89% vs -45.50% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 48.84 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -50.53% vs -28.92% in Dec 2023

Annual - Interest
Interest 0.87 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.10% vs -20.25% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.74%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023